Westfield Capital Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-805,916
Closed -$62.9M 257
2024
Q4
$62.9M Sell
805,916
-17,747
-2% -$1.39M 0.27% 114
2024
Q3
$66.2M Buy
823,663
+80,783
+11% +$6.49M 0.3% 109
2024
Q2
$61.5M Buy
742,880
+43,019
+6% +$3.56M 0.3% 110
2024
Q1
$59.7M Sell
699,861
-12,200
-2% -$1.04M 0.31% 114
2023
Q4
$60.9M Buy
712,061
+152,098
+27% +$13M 0.35% 111
2023
Q3
$50.2M Buy
559,963
+151,144
+37% +$13.5M 0.34% 116
2023
Q2
$34.8M Buy
408,819
+35,363
+9% +$3.01M 0.22% 145
2023
Q1
$30.9M Buy
373,456
+49,898
+15% +$4.13M 0.22% 148
2022
Q4
$25.4M Buy
323,558
+12,188
+4% +$959K 0.2% 150
2022
Q3
$23.1M Sell
311,370
-7,720
-2% -$572K 0.18% 159
2022
Q2
$20.8M Sell
319,090
-233,221
-42% -$15.2M 0.16% 167
2022
Q1
$34.9M Sell
552,311
-735,366
-57% -$46.5M 0.22% 136
2021
Q4
$68.3M Sell
1,287,677
-68,937
-5% -$3.66M 0.41% 85
2021
Q3
$95.8M Buy
1,356,614
+562,628
+71% +$39.7M 0.58% 54
2021
Q2
$52.9M Buy
793,986
+363,209
+84% +$24.2M 0.32% 119
2021
Q1
$47.8M Sell
430,777
-101,865
-19% -$11.3M 0.3% 119
2020
Q4
$63.3M Sell
532,642
-309,769
-37% -$36.8M 0.38% 90
2020
Q3
$73.5M Buy
842,411
+579,943
+221% +$50.6M 0.48% 67
2020
Q2
$23.5M Sell
262,468
-210,354
-44% -$18.8M 0.16% 157
2020
Q1
$47.1M Sell
472,822
-133,252
-22% -$13.3M 0.42% 86
2019
Q4
$69.6M Buy
606,074
+114,991
+23% +$13.2M 0.5% 69
2019
Q3
$61.9M Sell
491,083
-29,095
-6% -$3.67M 0.5% 71
2019
Q2
$62.6M Sell
520,178
-208,801
-29% -$25.1M 0.47% 74
2019
Q1
$63.8M Buy
728,979
+19,027
+3% +$1.66M 0.49% 71
2018
Q4
$71M Buy
709,952
+419,359
+144% +$42M 0.61% 63
2018
Q3
$33.3M Buy
+290,593
New +$33.3M 0.23% 143